ベンラファキシン誘発性セロトニン症候群による両側脳梗塞:症例報告
Nils Mein1, Khadija Mammadli2, Felix Luessi2
1Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.
Frontiers in stroke
|January 16, 2026
まとめ
ベンラファキシン過量投与はセロトニン症候群を引き起こし、虚血性脳損傷につながる可能性があります。この症例は、ベンラファキシン中毒による脳卒中、低血糖、痙攣発作などのまれな合併症を強調しています。
科学分野:
- 神経科学
- 毒物学
- 薬理学
背景:
- ベンラファキシンはセロトニン症候群を引き起こす可能性のある抗うつ薬です。
- セロトニン症候群は、生命を脅かす可能性のある状態です。
研究 の 目的:
- ベンラファキシン誘発性セロトニン症候群のまれな症例を報告すること。
- 虚血性脳卒中をベンラファキシン中毒の合併症として強調すること。
- 低血糖および痙攣発作の潜在的な合併症についての認識を高めること。
主な方法:
- ベンラファキシン過量投与患者の症例報告。
- 虚血性病変を評価するための脳MRI。
- セロトニン症候群の臨床モニタリングおよび対症療法。
主要な成果:
- MRIにおける両側皮質拡散制限パターンを伴うセロトニン症候群が患者に発症し、虚血性病変を示唆しました。
- 治療には、輸液、ベンゾジアゼピン系薬、高体温に対するパラセタモール、低血糖管理が含まれました。
- 患者は神経学的後遺症なく回復しました。
結論:
- ベンラファキシン中毒はセロトニン症候群および虚血性脳卒中につながる可能性があります。
- 低血糖およびてんかん性痙攣発作は、まれではあるが可能性のある合併症です。
- 早期認識と対症療法は、良好な転帰のために不可欠です。
関連する概念動画
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...


